Opinion on  Northwest Biotherapeutics Inc. New (NWBO)
Pure Speculation

Background: This is an over-the-counter stock (not AMEX or NASD listed) pharmaceutical company that recently was approved to sell its brain vaccine, the only one available, in Switzerland.  Based on this alone, it would seem that the company is worth more than $22 million, the current worth of the company, so perhaps it will head up on this news alone.  Don't forget to put in your stop loss orders at 25% (because penny stocks tend to have large fluctuations).  Trailing stop loss order recommended.